Jeil Pharmaceutical Co Ltd (271980) — Cash Flow Quality Index
Jeil Pharmaceutical Co Ltd (271980) has a Cash Flow Quality Index of 1.29x as of September 2025. Operating cash flow of ₩13.23 Billion exceeds net income of ₩10.28 Billion, indicating high earnings quality where cash backs reported profits. Explore Jeil Pharmaceutical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jeil Pharmaceutical Co Ltd Cash Flow Quality Index (2017–2023)
Historical Cash Flow Quality Index for Jeil Pharmaceutical Co Ltd across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of Jeil Pharmaceutical Co Ltd to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jeil Pharmaceutical Co Ltd (2017–2023)
Year-by-year earnings quality comparison for Jeil Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 271980 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -1.00x | ₩-4.98 Billion | ₩5.00 Billion | ▲ +63.9% |
| 2020 | -2.75x | ₩-19.05 Billion | ₩6.92 Billion | ▼ -124.2% |
| 2018 | 11.36x | ₩21.45 Billion | ₩1.89 Billion | ▲ +388.0% |
| 2017 | -3.94x | ₩-4.21 Billion | ₩1.07 Billion | — |